Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 06, 2021; 96 (14) Resident & Fellow Section

Child Neurology: Intractable Epilepsy and Transient Deficits in a Patient With a History of Herpes Simplex Virus Encephalitis

View ORCID ProfileGiovanna S. Manzano, View ORCID ProfileHusain H. Danish, View ORCID ProfileCatherine J. Chu, View ORCID ProfileEyal Y. Kimchi
First published January 25, 2021, DOI: https://doi.org/10.1212/WNL.0000000000011606
Giovanna S. Manzano
From the Department of Neurology, Massachusetts General Hospital, Boston.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giovanna S. Manzano
Husain H. Danish
From the Department of Neurology, Massachusetts General Hospital, Boston.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Husain H. Danish
Catherine J. Chu
From the Department of Neurology, Massachusetts General Hospital, Boston.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Catherine J. Chu
Eyal Y. Kimchi
From the Department of Neurology, Massachusetts General Hospital, Boston.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eyal Y. Kimchi
Full PDF
Citation
Child Neurology: Intractable Epilepsy and Transient Deficits in a Patient With a History of Herpes Simplex Virus Encephalitis
Giovanna S. Manzano, Husain H. Danish, Catherine J. Chu, Eyal Y. Kimchi
Neurology Apr 2021, 96 (14) 679-681; DOI: 10.1212/WNL.0000000000011606

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
56

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Herpes simplex virus (HSV) is a neurotropic pathogen that can invade, replicate, establish latency, and reactivate within the CNS.1 Potential triggers of reactivation include immunosuppression, fever, and direct insult.1,–,3 HSV reactivation may cause recurrence of an infectious process, herpes simplex encephalitis (HSE), or recurrence of a relatively benign condition, Mollaret meningitis. Here we report the case of a patient with intractable epilepsy following a febrile illness at age 2 thought to be secondary to HSV. She ultimately underwent an anterior corpus callosotomy 2 decades later with a postoperative course complicated by HSV reactivation. Whereas the majority of cases of HSV reactivation occur within the first year of illness, it is important to recognize that this virus may remain dormant for years and later reactivate in the setting of physiologic stress.

Clinical Case

New-Onset Seizures Following a Febrile Illness

A 2-year-old girl was developmentally normal until the onset of a febrile illness complicated by new-onset seizures. Her first seizure was prolonged and followed by persistent right hemiparesis, lasting 3 months. Diagnostic workup was notable for a brain MRI demonstrating asymmetric, nonenhancing hyperintensities in bilateral temporal lobes and insulae (figure, A and B). CSF analysis revealed pleocytosis (cell count unknown), normal protein, normal glucose, and negative HSV PCR. Antiepileptic drugs (AEDs) were initiated with adequate seizure control until age 4. At age 4, she developed transient right facial asymmetry associated with somnolence and headaches. A lumbar puncture revealed CSF lymphocytic pleocytosis (13 white blood cells, 76% lymph) and negative HSV PCR (protein and glucose unknown). A month later, she again experienced a prolonged seizure. This prompted a repeat lumbar puncture, which revealed worsened pleocytosis (54 white blood cells, 80% mono) and elevated protein (384 mg/dL). HSV PCR was not retested. A brain MRI showed additional new foci of T2 hyperintensity involving the corpus callosum, right insula, and right frontal lobe. A left temporal brain biopsy was performed and HSV viral cultures were negative. During subsequent months, she experienced transient steroid-responsive neurologic deficits. Eleven years after brain biopsy procurement, the specimens were reanalyzed. Prominent chronic inflammation in the leptomeninges, cortex, and superficial white matter with focal, non-necrotizing granuloma formation was appreciated. Antibody to HSV1 and 2 revealed scattered neuronal and glial cells with cytoplasmic staining. Sufficient tissue was not available for PCR-based diagnostics for HSV at time of reanalysis.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Brain MRI Reveals Persistent T2 Fluid-Attenuated Inversion Recovery (FLAIR) Hyperintensities Through Time

Axial T2 FLAIR brain MRI from presentations at age 3 (A, B) and age 23 (C, D) demonstrate diffuse hyperintensities involving the left temporal (A) and frontal (B) regions. Subtle hyperintensities also involve the right temporal and frontal regions (A and B). Corresponding sequences from the patient’s presentation at age 23 demonstrate expected postoperative changes following a prior left anterior temporal lobectomy (C, *) and recent anterior corpus callosotomy (D, arrowhead).

Worsening Epilepsy

At age 10, the frequency of clinical and subclinical electrographic seizures increased. This led to years of AED titration, vagus nerve stimulator placement, and a palliative left anterior temporal lobectomy at age 18, without complete seizure control. Subsequent development of frequent atonic seizures prompted the performance of an anterior corpus callosotomy at age 23. Immediately postoperatively, the patient was at her cognitive and behavioral baseline. Preoperative AEDs (cannabidiol, clobazam, lamotrigine, and levetiracetam) were continued postoperatively.

Postcallosotomy Course

On postoperative day 2 (POD2), the patient endorsed a new severe headache, lethargy, and a transient right facial droop. A noncontrast head CT displayed expected postoperative changes. On POD5, she was febrile (37.9°C), increasingly somnolent, markedly abulic, and exhibited psychomotor slowing. EEG showed no evidence of epileptic seizures. AED levels were therapeutic. A lumbar puncture revealed clear CSF with normal opening pressure (19 cm H2O), lymphocytic pleocytosis (34 and 29 white blood cells, 88% and 87% lymph), normal protein (32 mg/dL), normal glucose (61 mg/dL), and negative culture and positive HSV-1 DNA by PCR. A brain MRI with and without contrast demonstrated expected postsurgical changes (figure, C and D). A 3-week course of acyclovir monotherapy was administered. A slow steroid taper was concurrently completed. Her alertness and behavior gradually returned to preoperative baseline. She continues to remain free of atonic seizures postprocedurally.

Discussion

HSV is the most common cause of viral encephalitis in developed countries.2 The annual incidence of HSV-1 encephalitis in the United States is estimated to be 4,000 cases, with one-third of these cases affecting children.2 As per Infectious Diseases Society of America guidelines, adequate treatment of HSE requires a 3-week course of acyclovir.2 Although recurrence after completed therapy is thought to be uncommon, it has been reported in the literature. HSE recurrence occurs in approximately 5% of pediatric cases, commonly within weeks to months following initial infection.2 In contrast, patients with HSV-related chronic granulomatous inflammation may have intractable epilepsy and viral reactivation years from initial disease.4,–,6 Of note, the published cases of this unusual form of slow smoldering herpes encephalitis were first described after our patient's biopsy was performed. Detection of CSF HSV DNA by PCR is the gold standard for diagnosis of both initial and recurrent infection. This test may be falsely negative when tested too early in the disease course,2 if a sample has insufficient cells, or if a less-sensitive, qualitative assay is used. Our patient's intractable epilepsy is likely the sequelae of a remote episode of HSE complicated by chronic granulomatous inflammation. This is supported by her clinical course, histopathologic evidence, and positive HSV PCR during her most recent clinical event.

Several genetic mutations are associated with increased susceptibility to HSE and its recurrence. Most mutations involve the interferon-α/β and γ signaling pathways, as well as the toll-like receptor (TLR) pathway, specifically TLR3.2,5,6 These mutations are thought to disrupt cell-autonomous immunity in neurons and oligodendrocytes. Whole exome sequencing was performed for our patient. Interestingly, it did not detect any mutations or deficiencies known to confer an increased risk of HSE recurrence.

In addition to a recurrent infectious process, HSV reactivation may also cause a recurrent aseptic meningitis, termed Mollaret meningitis. In Mollaret meningitis, recurrent meningeal symptoms last for 2 to 5 days, then spontaneously resolve.7 This condition may also variably manifest with seizures, hallucinations, and altered mentation.7 Patients typically experience 3 to 10 lifetime events.7 CSF analysis reveals lymphocytic pleocytosis and HSV DNA by PCR is almost always positive, more commonly HSV-2. Although Mollaret meningitis is by definition a benign, self-resolving condition, IV acyclovir is administered for suspected cases.7

More recently, postinfectious inflammatory syndromes secondary to HSV have been recognized. Among these is a post-HSV autoimmune encephalitis mediated by NMDAR autoantibody.8,–,10 Anti-NMDA encephalitis is critical to identify because early immunotherapy can improve neurologic outcomes. Anti-NMDAR antibody was not tested during our patient's remote episodes. We have since tested our patient for NMDAR autoantibody and it is negative.

Although HSV is widely recognized as a devastating cause of acute encephalitis, it is important to acknowledge its potential long-term sequelae. We recommend that providers have a low threshold to obtain CSF for immunologic and viral testing when patients with a history of HSV develop recurrent neurologic symptoms. Symptom recurrence in this population may be due to either immune-mediated or virally mediated processes, each requiring targeted therapy. In our patient's case, identification of HSV-1 by PCR prompted a complete course of antiviral therapy with acyclovir, ultimately leading to clinical recovery.

Study Funding

No targeted funding reported.

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org/Nhttps://n.neurology.org/lookup/doi/10.1212/WNL.0000000000011606https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000011606 for full disclosures.

Appendix Authors

Table1

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • © 2021 American Academy of Neurology

References

  1. 1.↵
    1. Kleinschmidt-DeMasters BK,
    2. Gilden DH
    . The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol 2001;11:440–451.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Alsweed A,
    2. Alsuhibani M,
    3. Casanova J-L, et al
    . Approach to recurrent herpes simplex encephalitis in children. Int J Pediatr Adolesc Med 2018;5:35–38.
    OpenUrl
  3. 3.↵
    1. Mantero V,
    2. Cossu M,
    3. Rigamonti A, et al
    . HSV-1 encephalitis relapse after epilepsy surgery: a case report and review of the literature. J Neurovirol 2020;26:138–141.
    OpenUrl
  4. 4.↵
    1. Love S,
    2. Koch P,
    3. Urbach H, et al
    . Chronic granulomatous herpes simplex encephalitis in children. J Neuropathol Exp Neurol 2004;63:1173–1181.
    OpenUrl
  5. 5.↵
    1. Jay V,
    2. Becker L,
    3. Blaser S
    . Pathology of chronic herpes infection associated with seizure disorder: a report of two cases with tissue detection of herpes simplex virus 1 by polymerase chain reaction. Pediatr Pathol Lab Med 1995;15:131–146.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Asenbauer B,
    2. McEntagart M,
    3. King MD, et al
    . Chronic active destructive herpes simplex encephalitis with recovery of viral DNA 12 years after disease onset. Neuropediatrics 1998;29:120–123.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Lim HK,
    2. Seppänen M,
    3. Hautala T, et al
    . TLR3 deficiency in herpes simplex encephalitis. Neurology 2014;83:1888–1897.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Shalabi M,
    2. Whitley RJ
    . Recurrent benign lymphocytic meningitis. Clin Infect Dis 2006;43:1194–1197.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Armangue T,
    2. Moris G,
    3. Cantarín-Extremera V, et al
    . Autoimmune post–herpes simplex encephalitis of adults and teenagers. Neurology 2015;85:1736–1743.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Prüss H,
    2. Finke C,
    3. Höltje M, et al
    . N-Methyl-d-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012;72:902–911.
    OpenUrlCrossRefPubMed

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Clinical Case
    • Discussion
    • Study Funding
    • Disclosure
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • Post-infectious
  • All Immunology
  • All Epilepsy/Seizures
  • Autoimmune diseases
  • Viral infections

Alert Me

  • Alert me when eletters are published
Neurology: 96 (15)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise